Skip to main content
. 2013 Aug 1;208(12):1998–2006. doi: 10.1093/infdis/jit392

Table 1.

Estimates of Mutant Allele Frequencies from Clinical Specimens

Estimate (95% CI), %
Gene and Mutation Sangera Sanger–MLE 454–Pooled gDNA 454–Pooled DBS
dhfr (n = 50)
 N51I 80 (66.2–90) 78.92 (63.16–100) 70.91 (70.62–71.21) 72.70 (72.38–73.02)
 C59R 86 (73.3–94.2) 80.48 (64.56–100) 84.61 (84.38–84.85) 45.66 (45.30–46.02)
 S108N 88 (75.7–95.5) 86.16 (67.30–100) 90.2 (89.99–90.41) 96.62 (96.47–96.77)
 I164L 0 0 0 0
dhps (n = 46)
 S436A NA NA 12.78 (12.48–13.08) 18.41 (17.54–19.28)
 S436Y NA NA 0 0
 S436F NA NA 0 0
 A437G 60 (44.3–74.3)b 58.45 (43.89–82.89)b 55.11 (54.67–55.56) 54.86 (53.75–55.98)
 K540E 54.3 (39–69.1) 51.14 (40.09–68.87) 57.88 (57.47–58.29) 60.39 (59.46–61.33)
 A581G 2.2 (0–11.5) 1.09 (0–11.69) 6.19 (5.97–6.41) 6.35 (5.82–6.88)
 A613S NA NA 0 0
 A613T NA NA 0 0

Abbreviations: CI, confidence interval; DBS, dried blood spot; gDNA, genomic DNA; MLE, maximum likelihood estimation; NA, not available (chromatograms did not adequately cover loci).

a Percentage of mixed or mutant alleles.

b n = 45.